Eaton Vance Management Myriad Genetics Inc Transaction History

Eaton Vance Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$22.67 - $28.01 $21,717 - $26,833	-958 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$24.13 - $32.63 $17,470 - $23,624	-724 Reduced 43.04%	958 $0
Q3 2021 Nov 15, 2021	SELL	$29.97 - $36.66 $6,983 - $8,541	-233 Reduced 12.17%	1,682 $0
Q2 2021 Aug 16, 2021	BUY	$25.39 - $32.61 $33,870 - $43,501	1,334 Added 229.6%	1,915 $59,000
Q1 2021 May 17, 2021	BUY	$19.92 - $31.6 $11,573 - $18,359	581 New	581 $18,000

253

90.5M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.09B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

Stay updated on Eaton Vance Management with notifications on news.